Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Siemens seeks...

    Siemens seeks shareholders nod to hive off healthcare arm

    Written by savita thakur thakur Published On 2016-03-23T10:54:30+05:30  |  Updated On 23 March 2016 10:54 AM IST
    Siemens seeks shareholders nod to hive off healthcare arm
    New Delhi: German conglomerate Siemens sought shareholders' approval on the proposed sale and transfer of its healthcare undertaking in the country to its subsidiary Siemens Healthcare for a consideration of Rs 3,050 crore.

    "Siemens Ltd proposes to sell and transfer its Healthcare Undertaking as a 'going concern' and by way of a slump sale to Siemens Healthcare Pvt Ltd, a subsidiary of Siemens Aktiengesellschaft, Germany with effect from July 1, 2016 for a lump sum consideration of Rs 3,050 crore," the company said in a postal ballot notice to shareholders.

    "Accordingly, the proposed ordinary resolution and the statement setting out material facts thereof are being sent to you along with a Postal Ballot Form for your consideration," it added.

    The transaction will enable Siemens to increase its focus on, and capital allocation to power generation, transmission and distribution, mobility, industrial automation and smart cities segments in the country, Siemens India Managing Director and CEO Sunil Mathur has earlier said in a note.

    He said the deal enables Siemens AG to further strengthen its focus on the healthcare segment here by aligning it with its global strategy and management framework.

    The proposed transaction, recommended by the audit committee, is based on the valuation undertaken by two independent valuers Deloitte Touche Tohmatsu India and KPMG India.
    Deloitte Touche Tohmatsu IndiaKPMGPostal BallotSiemensSunil Mathur
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok